Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492309 · ClinicalTrials.gov registry record · NA

Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation

A NA study of Major Depressive Disorder, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT01492309 is a NA study of Major Depressive Disorder that has completed, run by University of Pennsylvania. The registered enrollment target is 22 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492309, a NA study of Major Depressive Disorder, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if repetitive transcranial magnetic stimulation (TMS) will alleviate symptoms of major depressive disorder (MDD) in pregnant women. TMS uses electromagnetic impulses to encourage neurons in the brain to communicate more effectively with one another. Effective neuron communication is thought to lead to the lessening of depressive symptoms. In this study subjects require daily TMS treatment for approximately four weeks.

Conditions Studied

Interventions

  • DEVICE Active Transcranial Magnetic Simulation
  • DEVICE Sham Transcranial Magnetic Stimulation

Study Locations (1)

Pennsylvania

  • Penn Center for Women's Behavioral Wellness - Philadelphia

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2011-11
Est. Completion 2017-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01492309

The ClinicalTrials.gov registry entry for NCT01492309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (94% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active Transcranial Magnetic Simulation is the first listed.

NCT01492309 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01492309 about?

NCT01492309 is a clinical study titled "Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation". The purpose of this study is to determine if repetitive transcranial magnetic stimulation (TMS) will alleviate symptoms of major depressive disorder (MDD) in pregnant women. TMS uses electromagnetic impulses to encourage neurons in the brain to communicate more effectively with one another. Effecti...

What is the current status of trial NCT01492309?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2011-11. Estimated completion is 2017-01.

What conditions does trial NCT01492309 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT01492309?

The interventions under investigation include: Active Transcranial Magnetic Simulation (DEVICE), Sham Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01492309?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01492309 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.